Magnus Financial Group LLC Sells 40 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Magnus Financial Group LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 4,973 shares of the healthcare conglomerate’s stock after selling 40 shares during the period. Magnus Financial Group LLC’s holdings in UnitedHealth Group were worth $2,516,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. International Assets Investment Management LLC grew its position in UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares during the period. Lone Pine Capital LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $480,903,000. Accredited Investors Inc. boosted its position in UnitedHealth Group by 9,235.4% in the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after buying an additional 776,516 shares in the last quarter. Raymond James & Associates raised its stake in shares of UnitedHealth Group by 33.1% in the third quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock valued at $1,380,661,000 after acquiring an additional 587,088 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec grew its position in UnitedHealth Group by 129.7% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after acquiring an additional 581,324 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on UNH shares. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Barclays lowered their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Finally, Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $627.74.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 1.1 %

NYSE:UNH opened at $519.08 on Thursday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $477.70 billion, a price-to-earnings ratio of 33.49, a PEG ratio of 1.42 and a beta of 0.62. The stock has a 50-day moving average price of $545.26 and a two-hundred day moving average price of $564.10.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. The business’s revenue was up 6.8% on a year-over-year basis. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.75 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.